Molecular Modeling Studies of Peptide Drug Candidates against SARS

Author(s): Rui Zhang, Dong-Qing Wei, Qi-Shi Du, Kuo-Chen Chou

Journal Name: Medicinal Chemistry

Volume 2 , Issue 3 , 2006

Become EABM
Become Reviewer


Flexible alignment and docking studies were conducted for the three octapeptides, ATLQANEV, AVLQSGFR, and ATLQAIAS, that were cleavable by SARS-CoV Mpro. It has been observed that all pharmacophores of the three peptides overlap very well, and that ATLQANEV binds best with the receptor, followed by AVLQSGFR, and then ATLQAIAS. During the process of docking the octapeptides to the SARS enzyme, the residues of the catalytic dyad, i.e., His-41 and Cys-145 are actively involved in forming the hydrogen bonds, so is the center residue (Gln) of all the three octapeptides. The findings are fully consistent with experimental observations. The present studies suggest that the octapeptides ATLQANEV and ATLQAIAS, like AVLQSGFR, might also be the good starting points for designing potential drugs against SARS.

Keywords: SARS, CoV Mpro, protease inhibitor, cleavable peptides, autodock, distorted key theory, flexible alignment, binding free energy

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2006
Page: [309 - 314]
Pages: 6
DOI: 10.2174/157340606776930736
Price: $65

Article Metrics

PDF: 3